Misako Nagasaka, M.D., assistant professor of Oncology at the Wayne State University School of Medicine, was selected for inclusion in the national 40 Under 40 in Cancer Class of 2020.
“This was a lucky win. I meant to nominate a colleague, who just happened to be over 40, so he nominated me instead,” said Dr. Nagasaka, of the Thoracic Oncology/Head and Neck Oncology Division.
“It is such an honor to be selected for this award and I am humbled to join the amazing group of clinicians and researchers across the nation. Together, I hope one day we get cancer under full control.”
The award, sponsored by the Lynx Group, Upstream Partners, Swim Across America and the National Community Oncology Dispensing Association Inc., identifies and recognizes the contributions being made by rising stars and emerging leaders younger than 40 in the United States.
Awardees were selected by a panel of experts in the field of oncology. Those selected for the recognition were honored during an online ceremony Oct. 15.
Dr. Nagasaka’s clinical and research interests are in molecular targeted therapy for lung cancer and head and neck tumors. She is also interested in immunotherapy and ways to improve outcomes. Having cared for many advanced-stage lung cancer and head and neck cancer patients, many of whom are experiencing therapeutic complications, Dr. Nagasaka’s focus is in using more practical regimens and providing survivorship care to patients.
In addition to her clinical work, Dr. Nagasaka has been heavily involved in clinical trials at the Barbara Ann Karmanos Cancer Institute. She has been a site principal investigator on more than 20 studies involving lung cancer.